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Abstract 
AIM: Study the cardiovascular risk factors in a feminine population vulnerable to cardiovascular events particularly 
to evaluate the principal factors or possible confounding variables. 
METHODS: This is a cross-sectional descriptive study. Were analysed all the female patients from the 
Cardiovascular Rehabilitation Institute of Sports Medicine of Caxias do Sul who had the complete information on 
cardiovascular disease history, comorbidities and habits and who knew the complete gynaecological history by a 
phone interview. 
RESULTS: A group of 91 patients were analysed. About the comorbidities and habits, 45.2% of these patients 
presented some tobacco load, 82.4% are hypertensive, 61.5% are dyslipidemic, 25.3% are diabetic and the BMI 
average was 29.27 (overweight). Between the patients who undergone a hysterectomy and had an episode of the 
acute coronary syndrome (10 patients), 70% had the event after the procedure. Between the post-menopause 
women with at least one episode of the acute coronary syndrome, 80.5% (33 patients) had the first event after the 
menopause. 
CONCLUSION: We found multiple lifetime risk factors that predisposed the women of the sample to have 
cardiovascular disease. Between the women with specific to women risk factors and without, the prevalence of 
cardiovascular disease was very similar. This information supports the idea that these are just confounding factors 
of CVD and the principals involved are the genetic factors and habits. For this reason, the focus of CVD 
prevention and treatment should be directed towards these aspects. 
 
 
 
 
 
 
Introduction 
 
Coronary Heart Disease (CHD) is an 
important Cardiovascular Disease category (CVD) 
and is considered the most common cause of death in 
the United States (USA) as well as in Brazil.  
Regarding epidemiology, diagnosis, treatment 
and prognosis of CVD, there are significant 
differences between men and women. These 
differences are extremely important for the care of 
women with a known or suspected disease and 
should be taken into consideration during medical 
care. In the past, CVD was considered a “male 
disease” since most studies excluded female patients 
or included them as a minority. However, this theory 
has been gradually disproved in light of new studies.  
According to the American Heart 
Association´s statistics for Heart Disease and  
Cerebrovascular Accident updated in 2010, 
17.6 million people have CVD in the USA, mainly men 
and women of more advanced age. The Framingham 
study showed that 40-year-old men have a lifetime 
risk of 49% to develop CVD while women, on the 
other hand, have a 32% risk. 70-year-old men have a 
35% risk, while women of the same age have 24%. 
Furthermore, the occurrence of CVD at the age of 65-
94 doubles in men and triples in women when 
compared to the incidence in the age range of 35-64 
[1].  
CVD generally manifests itself ten years later 
in women than in men and brings along an increased 
number of risk factors. Besides this, women tend not 
to identify its initial symptoms are delaying the 
moment of diagnosis and resulting in higher risk 
medical care. In pre-menopausal women, severe 
manifestations of CVD, such as acute myocardial 
infarction (MI) and sudden death, are relatively rare. 
On the other hand, in post-menopausal women, the 
 Tairova et al. Analysis of Cardiovascular Disease Risk Factors in Women 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2018 Aug 20; 6(8):1370-1375.                                                                                                                                                  1371 
 
occurrence and severity of CVD increase sharply 
(three times more comparing to pre-menopausal 
women). Clinical manifestations of CVD have 
similarities and differences between the sexes. Chest 
pain is similar in both sexes both in prevalence and in 
pain level. Acute MI prevalence is higher in men, 
however, prevalence tends to decrease in men and an 
increase in women as the years go by. Regarding 
Heart Failure (HF), women tend to develop 
asymptomatic HF secondary to CVD more frequently 
than men. Lastly, men seem to have a more 
increased rate of sudden cardiac death in all ages and 
all levels of risk factors.  
Apart from the classic CVD risk factors that 
are the same in men and women, existing literature 
describes that women also present unique risk 
factors. The first is menopause [2] during which the 
risk mechanism is not fully comprehended in the same 
way that it is not known if there is a direct causal 
relationship between menopause and CVD. 
Hysterectomy, oophorectomy, pre-menstrual 
syndrome, oral contraception and pregnancy 
complications such as systemic arterial hypertension 
(SAH), diabetes mellitus (DM), spontaneous abortion 
and preterm birth are also risk factors exclusive to 
women [3] [4] [5] [6].  
Age, family history, DM, chronic kidney 
disease and metabolic syndromes are related to a 
significant increase in the risk of cardiovascular 
events in both sexes [7]. Nonetheless, risk factors 
related to lipoproteins present some peculiarities in 
women: low HDL is more predictive for cardiovascular 
events in women than a high LDL; Lipoprotein A is a 
risk determinant for CVD in pre-menopausal and post-
menopausal women under the age of 66; the 
concentration of total cholesterol seems to be 
associated with CVD only in pre-menopausal women 
and triglycerides only in older women [8] [9]. A cross-
sectional study conducted in Rio Grande de Sul found 
that obesity is a more prevalent risk factor for women, 
while SAH is for men [10].  
Generally, women are a minority in CVR 
programs, and there are few studies on the subject, a 
fact that generates a lot of doubt about the handling 
and real evolution of women in these programs. 
Nevertheless, they seem to receive greater or similar 
benefits comparing to men [11].  
The prevalence and mortality of 
cardiovascular disease are growing, especially when it 
comes to women, who are increasingly younger. Due 
to the lack of studies that focus on understanding the 
natural history, handling and prevention of CVD in 
women better, we aim to study the cardiovascular risk 
factors in a feminine population vulnerable to 
cardiovascular events particularly to evaluate the 
principal factors or possible confounding variables.  
 
 
Methods 
 
This is a cross-sectional descriptive study. 
The population surveyed included patients from the 
Cardiovascular Rehabilitation Institute of Sports 
Medicine of Caxias do Sul (SMI).  
The data collection process for the study was 
conducted in three stages. Firstly, initial medical 
evaluation data were collected from all patients who 
entered the Cardiac Rehabilitation Service of SMI 
from 2007 to 2016 with several variables 
(identification, comorbidities, a medication used and 
exam results). Secondly, we selected all patients who 
fulfilled the following criteria: 1-female; 2-complete 
phone number data. In the end, we collected the 
gynaecological history by phone after making up to 
two attempts to contact patients during normal 
business hours. All data related to the gynaecological 
history of the patients were collected through an 
interview. The rest of the data was gathered from the 
initial evaluation made by a doctor of the service when 
the patient entered the CVR. After these proceedings, 
we used the following criteria for including patients in 
the study: 1-female; 2-Initial medical evaluation with 
complete information on cardiovascular disease 
history, comorbidities and habits; 3-Patient knows her 
complete gynaecological history. Exclusion criteria 
were as follows: 1-patients that did not recollect their 
complete gynaecological history; 2-incomplete initial 
medical evaluation; 3-unable to contact by phone after 
2 attempts.  
The initial medical evaluation variables taken 
into consideration were as follows: age of integration 
in the program, SAH (yes or no), DM (yes or no), 
dyslipidemia (yes or no), tobacco use (yes or no), 
body mass index (BMI), maximal oxygen uptake (VO2 
max) in ergometric tests or ergospirometry, acute 
coronary syndrome episode (ACS) (yes or no) and at 
what age the episode took place (pre or post-
menopause).  
The variables analyzed in the phone interview 
were the following: hysterectomy (yes or no), cause 
for hysterectomy (benign or malignant), oophorectomy 
(yes or no, and if yes how many ovaries were 
removed), use of oral contraception (if the patient has 
ever taken or not), use of hormonal replacement 
therapy (HRT), menarche (precocious; before the age 
of 11 [12], at the expected age, or late: after the age 
of 15 [13], menopause (didn’t take place, precocious: 
before the age of 40 [14], at the expected age, or late: 
after the age of 55 [14].  
The data was stored in an Excel® 2016 table 
and analysed with SPSS® software 22.0. We used 
descriptive statistics and a chi-square test for 
categorical variables to make the calculations.  
This research was approved by the Ethics 
and Research Committee of Faculdade Cenecista of 
Clinical Science 
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Bento Gonçalves and all participants in the study 
signed a consent statement accepting to participate. 
In the first phase, we chose 886 patients, 551 
of which were female. Among all women, only 352 
had informed their phone number. A first attempt was 
made to contact during business hours in which we 
find out that 142 (40.3%) patients had informed the 
wrong number or the information was out of date. 
Regarding the rest of the patients, we successfully 
contacted 112 cases (31.8%) and collected the 
gynaecological history of the patient through an 
interview conducted by the researchers. In the 
remaining 98 cases (27.9%) the phone number was 
correct. However, the patient did not have sufficient 
information regarding their gynaecological history or 
was unavailable to interview at the moment the call 
was made, even though we made up to two attempts 
to contact during business hours.  
After collecting the gynaecological history 
from 112 patients, 21 were excluded because of 
incomplete information in their medical chart. In total, 
we analysed 91 patients, which represented 16.7% of 
all female patients in the rehabilitation service.  
 
 
Results 
 
The evaluation of general clinical 
characteristics showed that practically one-third of the 
patients (33%) were ex-smokers and 13.2% were 
active smokers. In other words, 45.2% of patients 
presented some tobacco load, and the other 53.8% 
had never smoked. BMI average was 29.27 kg/m2 
with a standard deviation of 5.45. About the VO2max, 
23 patients (25.3%) did an ergometric test with the 
average VO2max being 19.87 ml/kg/min and a 
standard deviation of 7.64. The remaining 68 patients 
(74.7%) did the ergospirometric test obtaining an 
average VO2max of 14.81 ml/kg/min and a standard 
deviation of 6.23.  
Table 1: The prevalence of additional risk factors 
Comorbidity Yes No 
Diabetes 23 (25.3%) 68 (74.7%) 
SAH 75 (82.4%) 26 (17.6%) 
Dyslipidemia 56 (61.5%) 35 (38.5%) 
 
The analysis of variables related to 
gynaecological history showed that 66 patients 
(72.5%) did not have a hysterectomy. In the rest of the 
patients that informed having a hysterectomy, the 
majority (68%) did not know the reason for the 
surgery; one patient reported malignant cause and 
another 7 (28%) stated that it was a benign cause that 
motivated them to have the procedure. Regarding 
oophorectomy, 14 patients (15.4%) had the 
procedure, 5 of which (35.7%) removed just one ovary 
and 9 (64.3%) removed both ovaries. The median 
menarche age was 13 years (average 12.87), taking 
into consideration that 5 patients (5.5%) had 
menarche classified as precocious, 82 (90.1%) within 
the expected period and 4 (4.4%) late. About 
menopause, 8 patients were still pre-menopausal. 
From the remaining 83 women, 9 (10.8%) had early 
menopause, 70 (84.3%) within the expected period 
and 4 (4.8%) late. When it came to oral contraception, 
70 patients (76.9%) informed to have used 
contraception at some point in their life while 21 
(23.1%) denied use. About HRT, 24 patients (26.4%) 
reported having gone through HRT and 67 (73.6%) 
reported that they had never been through HRT.  
Lastly, around half of the patients (47.3%) had 
already had an ACS with the first episode taking place 
approximately at the age of 55 with a standard 
deviation of 11.42. Furthermore, the lowest age of the 
first ACS episode was 32 years and the highest 81 
years. Regarding the number of events of ACS, 79% 
of patients only had one episode, 16.3% had two 
episodes, and 4.7% had 5 episodes.  
Using the chi-square test, we analysed the 
women that had a hysterectomy and presented an 
ACS episode. This analysis resulted in a total of 10 
(11%) patients, 7 of which (70%) experienced the first 
ACS episode after a hysterectomy and the other 3 
(3%) experienced the first ACS episode before having 
a hysterectomy. The same observation was made 
about menopause, in that 33 women (80.5%) 
experienced the first ACS episode after menopause 
and 8 (19.5%) before menopause. In other words, 41 
patients (45%) reported having been through 
menopause and having had at least one ACS event. 
 
 
Discussion 
 
Our study analysed 91 female patients of a 
CVR service. While selecting the patients, we initially 
noticed a higher number of women than men. This 
data would contradict most existing studies on this 
subject [11]. We believe that either this data found in 
our program is incidental to the period analysed or 
that women presented more events or they sought out 
the rehabilitation program more than men.  
The metabolic profile of the participating 
women shows that most of them are hypertensive 
(82.4%), 61.5% are dyslipidemic, 25.3% are diabetic, 
and the BMI average was 29.27 (overweight). It is 
known that women have a greater prevalence of 
hypertension after the age of 50 and this prevalence 
tends to increase with age reaching up to 80-90% of 
women older than 70 years in the population [15] [16]. 
Regarding dyslipidemia, as it has already been 
explained, there are particularities in women. 
Prevalence also matches the population data, as it 
was shown in a study made in Sao Paulo according to 
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which the average hovers at around 60% [17]. 
Women also tend to have a greater prevalence of 
diabetes in the population; however, the DM 
prevalence analysed in our sample was significantly 
superior to the national average of prevalence in 
women (8.8%), possibly because of being part of a 
specific group with more CVD risk [7]. In general, 
despite the reduced number, the resulting metabolic 
profile matched the results of the population studies 
with a tendency for greater risk factor prevalence 
because of being a select group of patients.  
Practically half of the patients analysed 
(47.3%) experienced at least one episode of the acute 
coronary syndrome (ACS). The majority of the 
remaining patients have some kind of heart disease, 
mainly atherosclerotic, which makes us conclude that 
the group of patients under analysis is at high risk to 
develop a more severe event or even die. It is known 
that in Brazil, ischemic heart disease is one of the 
main causes of death and it is responsible for 31% of 
deaths caused by cardiovascular diseases while the 
Ischemic stroke is responsible for 30% of deaths 
caused by cardiovascular diseases. The age average 
for the first Acute Myocardial Infarction (AMI) matched 
the expected age based on other studies in which the 
age range for this event to be more likely is for women 
above the age of 50 [18]. Several studies show that 
the incidence of acute myocardial strokes grows 
drastically after menopause [19] [20] [21] and in some 
studies, a greater number of incidents was found 
among women with early menopause [2] [22]. There 
are various physiological explanations for such an 
occurrence. However, there is no concrete proof that 
menopause is a CVD causal factor. Some hypotheses 
are based on the fact that estrogen, just like 
progesterone, suppresses some endothelium and 
vascular smooth muscle proliferation factors mainly 
through intracellular receptors. There are studies 
which suggest that estrogen can stimulate the release 
of nitric oxide the same way progesterone stimulates 
COX-2 and consequently PGI2. Furthermore, 
estrogen aids in the lipolysis and lipogenesis 
responses, anti-inflammatory effects and antioxidants 
[21].  
Nevertheless, men also present an increase 
in cardiovascular events as the years go by, which 
weakens the theory that menopause is an 
independent causal factor of CVD [1]. Another factor 
that would contradict the estrogenic protection theory 
is the great change of habits in women and the 
increase of cardiovascular events in younger women, 
mainly related to the smoking habit and the stress at 
work and routine [23]. Men were not evaluated in our 
sample, and therefore we shall not hypothesise on 
this subject. In our sample, approximately 80.5% of 
the female patients that presented AMI during their 
lifetime suffered the event after menopause. Even if 
from a known physiological point of view this makes 
sense, we still cannot confirm a definite causal 
relationship based on this information.  
An important point to be discussed is about 
the genetic risk and healthy lifestyle. The evidence on 
this subject is well established in the literature, and 
the strong influence of these factors on increased 
cardiovascular risk must be taken into account. A 
study based on three prospective cohorts and one 
cross-sectional study showed that high genetic risk is 
independent of a healthy lifestyle and is associated 
with an increased risk (hazard ratio 1.91). There are 
up to 50 single-nucleotide polymorphisms related to 
CHD, and it is possible to calculate the polygenic risk 
score for this disease. Also, adherence into the 
healthy lifestyle (no current smoking, no obesity, 
regular physical activity, and a healthy diet) was 
associated with a significantly decreased risk, within 
any genetic risk category [24]. 
Due to the discoveries made about the 
protective cardiovascular role played by estrogen, 
many studies were conducted about HRT and 
cardiovascular prevention. However, many well-
conducted studies found exactly the contrary, an 
increased risk of several incidents with this type of 
therapy [25]. Given this, most global guidelines do not 
recommend the prescription of medication with a 
cardiovascular prevention purpose. Among the 
patients analysed in our study, 26.4% went through 
hormonal rehabilitation. There is a lack of data and 
sample size for the realisation of a persistent 
comparison of this type of therapy and cardiovascular 
events in our study.  
Apart from menopause, there are also 
assumptions related to the age of menarche and 
future risk for CVD. It is believed that early menarche 
is associated with a greater CVD risk and mortality 
caused by CVD [25]. In our sample, most patients had 
menarche at the expected age; therefore, this variable 
is difficult to analyse to link it to cardiovascular events.  
As far as oral contraception is concerned, it is 
known that the women who used this medication in 
the past do not have an increased risk for 
cardiovascular events [26]. There are only a few 
studies related to oral contraception use and events 
taking place at the same time and since the use is 
made at a younger age and cardiovascular events are 
extremely rare at this age group it is difficult to 
establish a relationship. Therefore, even if most of our 
patients had used this type of medication, we can be 
quite sure that there is little correlation between the 
number of cardiovascular events.  
Other analysed variables in our study were: 
going under hysterectomy and oophorectomy since 
there have been hypotheses of connection to 
increased CVD risk through undefined mechanisms. 
Very few patients of our study went through this 
procedure so it would be inappropriate to conclude the 
existence of any causal relationship. What´s more, 
according to bigger studies about this subject, the 
correlation between hysterectomy with or without 
ovary removal and cardiovascular events was not very 
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consistent, both in the pre-menopause and post-
menopause phase and for this reason, this hypothesis 
is hardly considered nowadays [3] [27].  
Our study was conducted with high-risk 
cardiovascular patients. The treatment choice for 
these patients needs to be very well planned with the 
interaction of drug and non-drug therapies. Taking this 
into consideration, CVR is a method that presents 
strong evidence of being a very important tool in the 
primary and secondary prevention for this kind of 
patient [28] [29]. However, there are very few studies 
specific to women and their evolution in this type of 
program.  
Bearing in mind that our study was conducted 
in a CVR program we can infer that, based on our 
data, the patients of the program have a very low 
functional capacity in their initial evaluation regardless 
their age range [30]. Most patients were evaluated 
with an ergospirometric test which is quite accurate for 
measuring such a variable. This is a positive point for 
our study since most research in CVR programs uses 
ergometric tests which overestimate results, as it was 
clearly shown in our findings.  
We can conclude that the patients analysed 
present various accumulated risk factors that 
predisposed them to CVD. Low functional capacity 
proves that they are critically ill patients who require 
meticulous care. Furthermore, there are specific risk 
factors for women that are still very controversial 
literature-wise. Although our sample presents risk and 
a high incidence of ACS, the theoretical risk factor 
rates specific to women (such as early menopause) 
were similar to the female population in general. 
Besides this, among the women in the analysed 
sample with and without risk factors specific to 
women, the ACS prevalence was similar.  
This information supports the idea that these 
are just confounding factors of CVD and the principals 
involved are the genetic factors and habits. For this 
reason, the focus of CVD prevention and treatment 
should be directed towards these aspects.  
 
Limitations 
The sample of the study ended up being 
limited due to lack of information in the charts and 
difficulty to contact patients, apart from the fact that 
the CVR public is of low numbers. What´s more, the 
average age of the initial evaluation was not taken into 
consideration in the study, as it was deemed more 
important to evaluate only the timeline of the exposure 
factors and outcome.  
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